Evidence map›Paper›PMID 35153505›Full record

ArticleInternational journal of general medicine2022

Protein Phosphatase 1 Regulatory Subunit 3: A Prognostic Biomarker in Stomach Adenocarcinoma.

Ya-Zhen Zhu, Xi-Wen Liao, Wu Yin, Hai-Ming Wei

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of general medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ya-Zhen ZhuDepartment of Pathology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Xi-Wen LiaoDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China.ORCID 0000-0002-1724-1463
Wu YinDepartment of Pathology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Hai-Ming WeiDepartment of Pathology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
The People's Hospital of Guangxi Zhuang Autonomous Region · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to determine the potential application of the protein phosphatase 1 regulatory subunit 3 ( MATERIALS AND

methodsDifferential expression analyses were performed using the TIMER2.0 and UALCAN databases. Complete RNA-seq data and other relevant clinical and survival data were acquired from The Cancer Genome Atlas (TCGA). Univariate survival analyses, Cox regression modelling, and Kaplan-Meier curves were implemented to investigate the associations between

resultsWe found that

conclusionOur findings demonstrate that the

Indexed as

mRNAPPP1R3Bprognosisprognostic biomarkersstomach adenocarcinoma

Identifiers

PMID35153505
PMCPMC8824296
OpenAlexW4210396506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.